Navigation Links
Genedata Announces Five-Year Agreement Extension with Kluyver Centre for Genomics of Industrial Fermentation
Date:3/23/2010

Bioinformatics Solution Provider to Support High Throughput Molecular Data Analysis and Result Sharing across Kluyver’s European Academic and Industrial Research Sites

Basel, Switzerland (PRWEB) March 23, 2010 -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced a five-year-extension of an ongoing collaboration with the Netherland’s Kluyver Centre, an industry and government consortium using microbial genomics to improve industrial fermentation processes. The Genedata Phylosopher biological data management platform and the Genedata Expressionist biomarker discovery platform will support central data storage and provide automated workflows to integrate transcriptomic, proteomic and metabolomic data for the centre’s academic and industrial research partners.

“We are able to pool genomics expertise across the entire Kluyver Centre network using Genedata’s standardized and integrated informatics platform,” explained Prof. Han De Winde, business director of the Kluyver Centre. “Our research focuses on the development of a complete systems biology workflow, which is aimed at enhancing fermentation in yeast, filamentous fungi or lactic acid bacteria. It also involves sequencing, genome-wide functional studies as well as strain and process design. We needed a research informatics partner able to support our full workflow and Genedata solutions are a perfect fit.”

The Kluyver Centre, a private-public partnership between fermentation experts from industry and academia, focuses on the highly innovative industrial systems biotechnology sector and includes microbial genomics, metabolic engineering, and bio-transformation programs. Part of the Netherlands Genomics Initiative, the Kluyver Centre develops sustainable and environmentally friendly production methods through fermentation of renewable feedstock, feed and feed ingredients, pharmaceutical compounds, and nutraceuticals.

“We are routinely applying various high-throughput omics technologies and use Genedata software for making sense of the huge data volumes produced by these technologies,” said Prof. Jack Pronk, scientific director of the Kluyver Centre. “Another great advantage of the Genedata software is that it supports emerging technologies such as next generation sequencing for in-depth transcriptome analysis, which is used for gene model refinement and re-sequencing-guided optimization campaigns of industrial production strains.”

“We are proud to expand our collaboration with the Kluyver Centre, a world-class white/industrial biotechnology research consortium,” said Dr. Othmar Pfannes, CEO of Genedata. Genedata is involved in several research consortia, and has developed computational solutions tailored for multi-site research programs. “In particular, our computational solutions for systems biotechnology anticipate the evolving needs of research groups adopting this approach and we look forward to continuing to support growth in this exciting field,” added Dr. Pfannes.

About the Kluyver Centre
The Kluyver Centre for Genomics of Industrial Fermentation is a consortium of Delft University of Technology, the universities of Leiden, Utrecht and Groningen, Wageningen University, VU University of Amsterdam, TI Food and Nutrition and NIZO food research. It employs microbial genomics to improve microorganisms for use in industrial fermentation processes. Fermentation is used in the production, from renewable feedstocks, of food products and ingredients, beverages, pharmaceutical compounds, nutraceuticals, and fine and bulk chemicals. The research covers five research programmes: Yeast for chemicals, fuels and beverages; Filamentous fungi for proteins and peptides; Lactic acid bacteria for fermented foods and food ingredients; systems biology of industrial micro-organisms, and Industrial genomics for society. For more information about the Kluyver Centre, please visit: www.kluyvercentre.nl.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery and life science research, which spans target, lead and biomarker discovery. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata Phylosopher, Genedata Screener, Genedata Expressionist, and Genedata AnalystTM make research data accessible and understandable, enabling scientific discovery that fights disease and improves health worldwide. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Japan, Germany and the US. www.genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.


###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3762244.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities
2. Genedata Expressionist with New Transcriptomics Biomarker Capabilities Advances Drug Development for Personalized Medicine
3. Genedata Screener Supports Small Molecule Research at the Broad Institute of Harvard and MIT
4. Genedata and the Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project
5. MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products
6. Genedata at HCA Announces Banner Year for Genedata Screener at Leading Pharmaceutical Companies
7. RIKEN Center for Genomics Medicine Chooses Genedata Expressionist for High Throughput Proteomics R&D
8. Evonik Extends Long-term Research & Development Partnership with Genedata
9. Bringing Statistics to Biologists - New Genedata Analyst Launches at Society of Toxicology 49th Annual Meeting
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 23, 2017 Atlas Genetics Ltd., the ... its Series D financing, raising $35 million from a syndicate ... Biotech. ... Development of the Atlas Genetics io® system has been completed ... test announced in February 2016.  This new Series D equity ...
(Date:1/21/2017)... ... January 20, 2017 , ... G&L Scientific Inc, ... industry ( http://www.gandlscientific.com ), has announced the opening of new offices in Cambridge, ... consultants and contractors. This is the latest step in G&L’s expansion of its ...
(Date:1/21/2017)... Aratana Therapeutics, Inc. (NASDAQ: PETX ... development and commercialization of innovative biopharmaceutical products for companion ... North America 2016. ... on the FDA approval of three innovative therapeutics in ... (capromorelin oral solution) and NOCITA ® (bupivacaine liposome ...
(Date:1/20/2017)... -- http://www.Financialbuzz.com - According to ... of death worldwide. There were 8.2 million cancer related ... deaths increased gradually over time, the death rates have ... cancers continues to drive demand of biological therapies for ... Insights, Inc. cancer biological therapy market size was USD 61.3 ...
Breaking Biology Technology:
(Date:12/15/2016)... Advancements in biometrics will radically ... wellbeing (HWW), and security of vehicles by ... vehicles begin to feature fingerprint recognition, iris ... monitoring, brain wave monitoring, stress detection, fatigue ... detection. These will be driven by built-in, ...
(Date:12/8/2016)... 2016 Market Research Future published a half cooked research ... Biometric Security and Service Market is expected to grow over the ... Market Highlights: ... Mobile Biometric Security and Service Market ... need of authentication and security from unwanted cyber threats. The increasing ...
(Date:12/7/2016)...   Avanade is helping Williams Martini Racing, ... history, exploit biometric data in order to critically analyse ... competitive edge against their rivals after their impressive, record-breaking ... has worked with Williams during the 2016 season to ... rate, breathing rate, temperature and peak acceleration) for key ...
Breaking Biology News(10 mins):